Earlier this off-season, I wrote that the Detroit Lions should re-sign Gosder Cherilus. In 2012, Cherilus was Mr. Dependable, as he was a part of every offensive snap for the team except one. The lonely snap that did not feature Cherilus was only because of his shoe being off. With rumors surrounding Cherilus off-season, the Lions might be passing on re-signing the offensive lineman.
The Detroit Free Press ran a story that Cherilus had undergone surgery for Regenokine, a blood manipulation disease, in January. The rumors were started from a picture put up on Facebook of Cherilus with Dr. Peter Wehling. The famous doctor will not confirm whether he worked on Cherilus, but has said he has helped over 30 NFL players.
Cherilus was in Germany at some point this off-season. The surgery option from Dr. Wehling is not FDA approved in the United States. When asked about the surgery by the paper Cherilus did not sound happy and failed to confirm the rumor. Cherilus had this to say, “I didn’t get any treatment done, and what I do during the offseason is not ur business.”
Surgery wouldn’t be the first issue for Cherilus. The Lions lineman had microsfracture surgery in 2010 and has had knee issues. Regenokine surgery has a high success rate with athletes like Kobe Bryant, Alex Rodriguez, and Brian Urlacher returning from similar procedures.
If the Lions chose not to re-sign Cherilus, they have Riley Reiff available to take his place. I’m guessing the team doesn’t re-sing him as they need help on the defensive line and secondary. Cherilus made $2.3 million in 2012 base salary and $4.6 million overall.